Bionomics (BNOX) Soars After Securing AUS$1M Milestone Payment from Carina Biotech; Shares Up 185%
    Bionomics (BNOX) Soars After Securing AUS$1M Milestone Payment from Carina Biotech; Shares Up 185%
    PRISM Biotech

    November 05, 2024  - by Alex Corbit

    Bionomics (BNOX) Soars After Securing AUS$1M Milestone Payment from Carina Biotech; Shares Up 185%

    05 November 2024

    New York, November 05, 2024 - PRISM MarketView - Bionomics Limited (NASDAQ: BNOX), a biotech company specializing in treatments for central nervous system disorders, has received a milestone payment of AUS$1 million from Carina Biotech. This payment is part of an exclusive worldwide license agreement for BNC101, a monoclonal antibody targeting the cancer stem cell antigen LGR5, which Carina is investigating for CAR-T cell therapies in solid cancers, including metastatic colorectal cancer. The deal includes further potential payments that could total around AUS$118 million in development, regulatory, and commercial milestones.

    Bionomics Limited - Prism MarketView

    Bionomics (Nasdaq: BNOX, ASX:BNO) is a clinical-stage biopharmaceutical developing novel, allosteric ion channel modulators designed to transform the lives of p

    Read More

    Bionomics’ CEO, Dr. Spyros Papapetropoulos, highlighted the payment as validation of the company’s scientific expertise. Bionomics stands to receive additional royalties and a share of sublicensing revenues under the agreement. The company is also advancing its lead candidate, BNC210, in phase 3 trials for social anxiety disorder and PTSD, and has a strategic partnership with Merck valued at around US$500 million to develop treatments for cognitive dysfunction in Alzheimer’s and other CNS conditions.
    In response to this positive news, Bionomics’ shares are up 185% today.
    About PRISM MarketView:
    Established in 2020, PRISM MarketView is dedicated to the monitoring and analysis of small cap stocks in burgeoning sectors. We deliver up-to-the-minute financial market news, provide comprehensive investor tools and foster a dynamic investor community. Central to our offerings are proprietary indexes that observe emerging sectors, including biotech, clean energy, next-generation tech, medical devices and beyond. Visit us at prismmarketview.com and follow us on X.
    To see this content properly accept cookies.
    Disclaimer:
    PRISM MarketView is not a registered or licensed broker-dealer or investment adviser and does not offer investment advice. The information provided in this communication is not intended to constitute an offer to sell, a solicitation of an offer to buy, or a recommendation for any security.
    Contact:
    PRISM MarketView
    info@prismmarketview.com
    646-863-6341
    To see this content properly accept cookies.
    Prism MarketView | Stock Market News & Investment Opportunities
    To see this content properly accept cookies.
    We use cookies to run our website, analyze your use of our services, manage your online preference & personalize ad content. By accepting our cookies, you’ll get relevant content and social media features, personalized ads, and an enhanced browsing experience. To manage your choices, click „Cookie Settings”. Necessary cookies are required for the core website functionality and cannot be rejected. For more information, see our Cookie Policy.
    Cookie settings
    Cookies used on the site are categorized and below you can read about each category and allow or deny some or all of them, except for Necessary Cookies which are required to provide core website functionality. When categories that have been previously allowed are disabled, all cookies assigned to that category will be removed from your browser. You can see a list of cookies assigned to each category and detailed information on those cookies in the “Cookie Policy” tab.
    Necessary cookies
    Some cookies are required to provide core functionality. The website won't function properly without these cookies and they are enabled by default and cannot be disabled.
    Preferences
    Preference cookies enables the website to remember information to customize how the website looks or behaves for each user. This may include storing selected currency region, language or color theme.
    Analytical cookies
    Analytical cookies help us improve our website by collecting and reporting information on its usage.
    Marketing cookies
    Marketing cookies are used to track visitors across websites to allow publishers to display relevant and engaging advertisements. By enabling marketing cookies, you grant permission for personalized advertising across various platforms.